AtaiBeckley Inc. Common Stock (ATAI)
Stock · NASDAQ · Health Care
$7.29as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$4.04
Industry
Biotechnology: Pharmaceutical Preparations
AtaiBeckley Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ATAIAtaiBeckley Inc. Common Stock$7.29▼ 0.82%Market cap $2.64BP/E —
- SUPNSupernus Pharmaceuticals Inc. Common Stock$43.76▼ 0.97%Market cap $2.67BP/E —$42.45$59.68
- IMNMImmunome Inc. Common Stock$27.57▼ 4.50%Market cap $2.61BP/E —$8.67$30.06
- TRVITrevi Therapeutics Inc. Common Stock$16.78▼ 6.60%Market cap $2.54BP/E —$6.93$20.22
- RAREUltragenyx Pharmaceutical Inc. Common Stock$25.62▼ 2.46%Market cap $2.46BP/E —$18.29$39.89
- NKTRNektar Therapeutics Common Stock$72.57▼ 2.66%Market cap $2.38BP/E —$27.87$109
- IRONDisc Medicine Inc. Common Stock$80.01▼ 3.08%Market cap $2.93BP/E —$40$99.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ATAI AtaiBeckley Inc. Common Stock | $2.64B | — | $7.29 | ▼ 0.82% | |
| SUPN Supernus Pharmaceuticals Inc. Common Stock | $2.67B | — | $43.76 | ▼ 0.97% | $42.45$59.68 |
| IMNM Immunome Inc. Common Stock | $2.61B | — | $27.57 | ▼ 4.50% | $8.67$30.06 |
| TRVI Trevi Therapeutics Inc. Common Stock | $2.54B | — | $16.78 | ▼ 6.60% | $6.93$20.22 |
| RARE Ultragenyx Pharmaceutical Inc. Common Stock | $2.46B | — | $25.62 | ▼ 2.46% | $18.29$39.89 |
| NKTR Nektar Therapeutics Common Stock | $2.38B | — | $72.57 | ▼ 2.66% | $27.87$109 |
| IRON Disc Medicine Inc. Common Stock | $2.93B | — | $80.01 | ▼ 3.08% | $40$99.5 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 97.83M
- Total value held
- $345.95M
- Institutional holders
- 172
Top holders this quarter
- Unknown12.00M
- Unknown11.76M
- Unknown7.43M
- Unknown6.84M
- Unknown6.00M
- Unknown5.64M
- Unknown4.36M
- Unknown3.85M
- Unknown3.09M
- Unknown2.89M
See the full, filterable feed with live charts on the MarketWall dashboard.